丹麦2001至2009年诊断为糖尿病的139,075人中筛查2型糖尿病对心血管疾病和死亡风险的影响:一项对照试验
在丹麦基于注册的非随机对照试验中,2001至2006年向153,107人发放糖尿病风险问卷进行筛查,2001至2009年筛查组诊断糖尿病13,992人、非筛查组125,083人。2001至2012年间,筛查组糖尿病患者心血管疾病风险HR 0.84(95%CI 0.80, 0.89)、死亡风险HR 0.79(95%CI 0.74, 0.84),均低于非筛查组。作者认为单轮筛查与糖尿病患者全因死亡和心血管事件风险显著降低相关。
要点
- 筛查组糖尿病患者心血管疾病风险HR 0.84(95%CI 0.80, 0.89),低于非筛查组。
- 筛查组糖尿病患者死亡风险HR 0.79(95%CI 0.74, 0.84),低于非筛查组。
- 筛查组153,107人中27,177人(18%)参加筛查,其中1,533人诊断糖尿病。
核心结论
- 在丹麦中老年成人全科医疗中开展单轮糖尿病筛查和心血管风险评估,与糖尿病患者全因死亡和心血管事件风险显著降低相关。
研究设计与样本
- 基于注册的非随机对照试验,纳入丹麦40-69岁无已知糖尿病且在全科诊所注册的男女共1,912,392人。
- 2001至2006年向参与ADDITION-丹麦研究的181家诊所注册的153,107人发放糖尿病风险问卷,中高危者受邀至家庭医生处评估糖尿病状态和心血管风险(筛查组)。
- 丹麦其他所有诊所注册的1,759,285人构成回顾性构建的无筛查(对照)组。
- 事后分析识别2001至2009年筛查组和非筛查组中诊断为糖尿病者共139,075人,比较2001至2012年两组心血管疾病和死亡风险。
主要发现
- 筛查组153,107人中27,177人(18%)参加筛查,其中1,533人诊断糖尿病。
- 2001至2009年筛查组新诊断糖尿病13,992人(包括经筛查诊断者),非筛查组125,083人。
- 2001至2012年筛查组糖尿病患者心血管疾病风险HR 0.84(95%CI 0.80, 0.89),低于非筛查组糖尿病患者。
- 2001至2012年筛查组糖尿病患者死亡风险HR 0.79(95%CI 0.74, 0.84),低于非筛查组糖尿病患者。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: There is continuing debate about the net benefits of population screening for type 2 diabetes. We compared the risk of cardiovascular disease (CVD) and mortality among incident cases of type 2 diabetes in a screened group with those in an unscreened group. METHODS: In this register-based non-randomised controlled trial, eligible individuals were all men and women aged 40-69 years without known diabetes, registered with a general practice in Denmark (n = 1,912,392). Between 2001 and 2006, 153,107 individuals registered with 181 practices participating in the Anglo-Danish-Dutch Study of Intensive Treatment in People with Screen-Detected Diabetes in Primary Care (ADDITION)-Denmark study were sent a diabetes-risk-score questionnaire. Individuals at moderate-to-high risk were invited to visit their family doctor for assessment of diabetes status and cardiovascular risk (screening group). The 1,759,285 individuals registered with all other practices in Denmark constituted the retrospectively constructed no-screening (control) group. In this post hoc analysis, we identified individuals from the screening and no-screening groups who were diagnosed with diabetes between 2001 and 2009 (n = 139,075), and compared risk of CVD and mortality in these groups between 2001 and 2012. RESULTS: In the screening group, 27,177/153,107 (18%) individuals attended for screening, of whom 1533 were diagnosed with diabetes. Between 2001 and 2009, 13,992 people were newly diagnosed with diabetes in the screening group (including those diagnosed by screening) and 125,083 in the no-screening group. Between 2001 and 2012, the risks of CVD and mortality were lower among individuals with diabetes in the screening group compared with individuals with diabetes in the no-screening (control) group (CVD HR 0.84, 95% CI 0.80, 0.89; mortality HR 0.79, 95% CI 0.74, 0.84). CONCLUSIONS/INTERPRETATION: A single round of diabetes screening and cardiovascular risk assessment in middle-aged Danish adults in general practice was associated with a significant reduction in risk of all-cause mortality and CVD events in those diagnosed with diabetes.
引用
- Simmons RK, Griffin SJ, Lauritzen T, et al. Effect of screening for type 2 diabetes on risk of cardiovascular disease and mortality: a controlled trial among 139,075 individuals diagnosed with diabetes in Denmark between 2001 and 2009. Diabetologia. 2017. PMID: 28831539. doi:10.1007/s00125-017-4299-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。